Results 921-940 of 1,067,257 for in 'Dáil debates' OR in 'Committee meetings' speaker:Rory O'Hanlon

Ceisteanna Eile - Other Questions: Disease Management (26 Jun 2025)

Disease Management

Ceisteanna Eile - Other Questions: Disease Management (26 Jun 2025)

Naoise Ó Muirí: 9. To ask the Minister for Health the status of the chronic disease Mmnagement programme; the number of patients now enrolled; and if she will make a statement on the matter. [34666/25]

Ceisteanna Eile - Other Questions: Disease Management (26 Jun 2025)

Jennifer Carroll MacNeill: The GP chronic disease management programme commenced in 2020 and has been rolled out on a phased basis over four years to adults with either a medical card or, for GMS patients, a GP visit card. The aim of the programme is to prevent and manage chronic diseases. Since 2020, over 680,000 patients have been registered on the programme, including those who have exited the programme. Some 91%...

Ceisteanna Eile - Other Questions: Disease Management (26 Jun 2025)

Naoise Ó Muirí: I am looking at this programme and it seems to be a quiet success story for the HSE. We hear very little about it. The Minister mentioned statistics regarding fewer presentations at emergency departments. That is a very good measure of success. The Minister mentioned some additional conditions that will be brought into it. I think she mentioned hypertension. It would be useful to have...

Ceisteanna Eile - Other Questions: Disease Management (26 Jun 2025)

Jennifer Carroll MacNeill: That is right. It impacts early detection as well. As populations age - which ours is doing - the prevalence of chronic conditions, including multimorbidity, rises. Early protection through the chronic disease management programme prevents the need for more intensive hospital-based treatments. Since 2020, 51% of the new chronic disease diagnoses have been made through elements of this...

Ceisteanna Eile - Other Questions: Regulatory Bodies (26 Jun 2025)

Kieran O'Donnell: The context here is quite simple. I always go back to the needs of older persons in nursing homes. What we saw in that programme with the residents in the nursing homes in Portlaoise and Beneavin was wanton neglect and abuse of older people. We want to look at the regulatory system and how we can improve it. All aspects will be considered. This is ultimately about improvements and...

Ceisteanna Eile - Other Questions: Regulatory Bodies (26 Jun 2025)

Jennifer Carroll MacNeill: It is exceptionally important to acknowledge that our focus here is on HIQA, but HIQA did not do and did not enable what happened in the nursing homes. I want to take a moment to reflect on the fact that the provider and the individuals involved are ultimately responsible. We will also work with HIQA but let us first and foremost direct our ire at the providers of the nursing homes.

Ceisteanna Eile - Other Questions: Medicinal Products (26 Jun 2025)

Medicinal Products

Ceisteanna Eile - Other Questions: Medicinal Products (26 Jun 2025)

Shane Moynihan: 7. To ask the Minister for Health if the Belgian model is being examined in the context of the programme for Government commitment to investigate early access schemes for rare disease treatments; and if she will make a statement on the matter. [34617/25]

Ceisteanna Eile - Other Questions: Medicinal Products (26 Jun 2025)

Shane Moynihan: The Minister is no doubt aware of the cases of those who suffer with Duchenne muscular dystrophy, a matter which has been raised in the Dáil a number of times, as well as with the Minister directly, not least because of the Thompson boys in my own constituency. This has brought into focus the need for an early access scheme for rare disease drugs. I know there is a commitment to this...

Ceisteanna Eile - Other Questions: Medicinal Products (26 Jun 2025)

Jennifer Carroll MacNeill: I recognise the importance of timely access for patients to medicines, including new medicines. Supported by €128 million of funding, in the past four years the State has delivered access to 194 new medicines. Of these, 74 were for cancer and 49 were for rare diseases. Budget 2025 allocated €30 million for new medicines, to come from efficiencies to be identified by the HSE....

Ceisteanna Eile - Other Questions: Medicinal Products (26 Jun 2025)

Shane Moynihan: It is great to hear about the progress that has been made in implementing the recommendations of the Mazars report on this subject that was published some years ago. That goes to the heart of the extra resourcing that the Minister spoke about. She is right; there needs to be a partnership between industry and the State to make sure that these applications are put through immediately and...

Ceisteanna Eile - Other Questions: Medicinal Products (26 Jun 2025)

Jennifer Carroll MacNeill: I want to put a little bit of context on this. The State spent more than €3 billion in 2023 providing medicines to patients. We sometimes forget that €3 billion of the health spend goes to providing medicines. That is appropriate but it is a major budgetary consideration as well. With the early access programmes, we have to get the balance right between being able to get...

Ceisteanna Eile - Other Questions: Medicinal Products (26 Jun 2025)

Shane Moynihan: I appreciate the efforts of the Minister in this regard and I have conveyed that to the families involved. I am very grateful for the Minister's proactive approach. The beauty of getting an early access scheme right is that it does not necessarily rely on the proactivity of the State to be involved in that process but, rather, the partnership is hardwired into every piece of the system and...

Ceisteanna Eile - Other Questions: Medicinal Products (26 Jun 2025)

Jennifer Carroll MacNeill: I will do so, Deputy.

Ceisteanna Eile - Other Questions: Medicinal Products (26 Jun 2025)

Questions Nos. 8 and 10 taken with Written Answers.

Ceisteanna Eile - Other Questions: Hospital Procedures (26 Jun 2025)

Hospital Procedures

Ceisteanna Eile - Other Questions: Hospital Procedures (26 Jun 2025)

Ruairí Ó Murchú: 11. To ask the Minister for Health the mechanism by which parents whose children were and are deemed to need hip dysplasia surgery at CHI hospitals at Temple Street and Cappagh will be able to get independent second opinions by experts of their choosing paid for by the HSE; and if she will make a statement on the matter. [33749/25]

Ceisteanna Eile - Other Questions: Hospital Procedures (26 Jun 2025)

Ruairí Ó Murchú: I want to ask the Minister the mechanism by which parents whose children are deemed to need hip dysplasia surgery at CHI hospitals such as Temple Street and Cappagh will be able to get independent second opinions by experts of their choosing, paid for by the HSE? I have spoken to the Minister on this previously and I believe she was working with Bernard Gloster on finding a solution to this...

Ceisteanna Eile - Other Questions: Hospital Procedures (26 Jun 2025)

Jennifer Carroll MacNeill: I agree completely with the Deputy. However, my immediate priority is to ensure that there is clinical follow-up and care for patients who have undergone pelvic osteotomy surgery in accordance with the recommendations of the Thomas audit report. I am very aware that there are families around Ireland who are receiving letters and follow-up to say that surgery was not necessary on their...